STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Consumer Cyclical Auto Manufacturers

Goldman Sachs Slashes U.S. Auto Sales Forecast Amid Tariff Pressures

byLuca Blaumann
April 10, 2025
in Auto Manufacturers, Large-Cap
Reading Time: 2 mins read
Share on TwitterShare on LinkedIn

Higher vehicle costs and softening demand prompt nearly 1 million-unit cut for 2025 outlook

Goldman Sachs (GS) has sharply reduced its U.S. auto sales forecast for 2025, citing the impact of tariffs that are expected to significantly raise vehicle costs. The Wall Street firm now projects 15.40 million units will be sold next year, down from its earlier estimate of 16.25 million.

Although President Donald Trump paused reciprocal tariffs on most countries—excluding China—for 90 days, auto-related duties on steel, aluminum, and vehicles remain intact. These ongoing tariffs are expected to raise the average cost of both importing and manufacturing vehicles in the U.S. by several thousand dollars, according to analysts led by Mark Delaney.

The investment bank anticipates that new vehicle prices will rise by approximately $2,000 to $4,000 over the next 6 to 12 months as automakers attempt to absorb the additional costs. However, with consumer demand already softening, the industry may struggle to fully pass these costs on to buyers.

Goldman also reduced its 2026 U.S. auto sales forecast to 15.25 million units, down by 1.1 million. Global auto production estimates for this year were revised to 88.7 million units from 90.4 million, with a similar cut to 2026 forecasts.

Amid the revisions, Goldman downgraded Ford’s stock to ‘neutral’ from ‘buy’, citing rising costs, global competition, and weak demand. Ford recently introduced broad discounts to move inventory and stimulate sales ahead of anticipated price increases.

The news weighed heavily on automakers. Ford shares slipped nearly 5% in morning trading, while General Motors dropped 5.2%. Stellantis took the hardest hit, plunging 11.8%.

You might like this article:Delta Airlines Revenue Stalls Amid Trade Uncertainty and Weaker Corporate Travel

Tags: BreakingFGMGrowthMoversNewsSTLAStock Market
Previous Post

Delta Airlines Revenue Stalls Amid Trade Uncertainty and Weaker Corporate Travel

Next Post

NATO Taps Palantir’s AI-Powered Maven System in Landmark Defense Deal

Related Posts

drugs-4

Hims & Hers Shares Plunge as FDA Tightens Grip on Compounded GLP-1 Drugs

byLuca Blaumann
February 9, 2026
0

Regulatory crackdown and Novo Nordisk lawsuit rattle investors and reshape weight-loss drug landscape Shares of Hims & Hers Health (HIMS)...

vehicle-fleet

Stellantis Takes $26 Billion EV Write-Down as Electrification Strategy Resets

byLiliana Vida
February 6, 2026
0

Automaker posts 2025 net loss after acknowledging missteps in the pace of the energy transition Stellantis shocked markets after announcing...

Reddit Enters a New Growth Era as Profits Surge and Share Buyback Signals Confidence

byLuca Blaumann
February 5, 2026
0

Explosive revenue growth, rising engagement, and strong cash generation reshape Reddit’s investment narrative Reddit (RRDT) closed out 2025 with a...

Next Post

NATO Taps Palantir's AI-Powered Maven System in Landmark Defense Deal

Latest News

FDA Flags Novo Nordisk’s Wegovy Pill Ad for Misleading Claims

Oracle Rebounds as Big Tech’s AI Spending Revives Software Optimism

Hims & Hers Shares Plunge as FDA Tightens Grip on Compounded GLP-1 Drugs

Stellantis Takes $26 Billion EV Write-Down as Electrification Strategy Resets

Dentsply Sirona’s $45 Bull Case: A Turnaround Leveraged to a Dental Recovery

Based on Your Interest

Entertainment

Reddit Enters a New Growth Era as Profits Surge and Share Buyback Signals Confidence

February 5, 2026
amazon
Ecommerece

Amazon Beats Earnings, but Massive AI Spending Spooks Investors

February 5, 2026
Gold

Silver’s Historic Rout Exposes the Dark Side of Speculative Mania

February 5, 2026

Recommended

Artificial Intelligence

Alphabet’s AI Bet Shakes Investors, but Fundamentals Stay Strong

February 5, 2026
Bitcoin

Bitcoin Slides After Treasury Pushback Signals No Government Backstop

February 4, 2026
Artificial Intelligence

Advanced Micro Devices Beats Earnings, but Shares Slide as AI Expectations Stay Sky-High

February 4, 2026
Artificial Intelligence

Intel Signals GPU Ambitions in Bid to Reclaim Data Center Relevance

February 3, 2026
Artificial Intelligence

Earnings Season Hits a Crucial Stretch as Tech Strength Meets Consumer Caution

February 3, 2026
Stoxpo

Follow us on social media:

Highlights

  • FDA Flags Novo Nordisk’s Wegovy Pill Ad for Misleading Claims
  • Oracle Rebounds as Big Tech’s AI Spending Revives Software Optimism
  • Hims & Hers Shares Plunge as FDA Tightens Grip on Compounded GLP-1 Drugs
  • Stellantis Takes $26 Billion EV Write-Down as Electrification Strategy Resets
  • Dentsply Sirona’s $45 Bull Case: A Turnaround Leveraged to a Dental Recovery

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

drugs-2

FDA Flags Novo Nordisk’s Wegovy Pill Ad for Misleading Claims

February 9, 2026
investing

Oracle Rebounds as Big Tech’s AI Spending Revives Software Optimism

February 9, 2026
drugs-4

Hims & Hers Shares Plunge as FDA Tightens Grip on Compounded GLP-1 Drugs

February 9, 2026
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.